Ylide Ligands as Building Blocks for Bioactive Group 11 Metal Complexes

Area of Science:

• Organometallic Chemistry
• Coordination Chemistry
• Medicinal Chemistry

Background:

• The reactivity of phosphonium salts and ylides with transition metals is crucial for developing new compounds.
• Group 11 metals (copper, silver, gold) offer unique electronic and structural properties for complex formation.
• Understanding structure-activity relationships is key to designing effective therapeutic agents.

Purpose of the Study:

• To investigate the reactivity of (cyanomethyl)triphenylphosphonium ylide with Group 11 metal complexes.
• To synthesize and characterize novel mononuclear and cationic gold, silver, and copper complexes.
• To evaluate the in vitro cytotoxic activity of these metal complexes against A549 human lung carcinoma cells.

Main Methods:

• Synthesis of phosphonium salt and ylide precursors.
• Reaction of ylide with gold(I), gold(III), silver, and copper precursors.
• Characterization using spectroscopic techniques and X-ray crystallography.
• In vitro cytotoxicity assays using the A549 cell line.

Main Results:

• Mononuclear neutral and cationic gold complexes were successfully synthesized, requiring sterically demanding ligands for cationic species.
• Silver and copper complexes adopted dimeric or polymeric structures involving cyano group coordination.
• Gold complexes formed mononuclear species, while silver complexes showed a 2D polymeric structure.
• Complexes possess two chiral centers; gold compounds yielded diastereoisomers, while silver and copper derivatives produced single diastereoisomers.
• All synthesized metal complexes demonstrated excellent in vitro cytotoxic activity against A549 cells, with IC50 values superior to cisplatin.

Conclusions:

• The study successfully synthesized novel Group 11 metal complexes with a phosphonium ylide, revealing distinct structural preferences between gold and other metals.
• The synthesized gold, silver, and copper complexes exhibit potent cytotoxic effects against human lung carcinoma cells, suggesting their potential as anticancer agents.
• These findings highlight the therapeutic promise of these organometallic compounds and warrant further investigation for drug development.